Read + Share
Amedeo Smart
Independent Medical Education
Shi R, Wolgemuth DJ, Georg GI. Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review. Contraception 2025 Jan 3:110809. doi: 10.1016/j.contraception.2024.110809.PMID: 39756562
Email
LinkedIn
Privacy Policy